The LiquidBiopsy Platform simplifies the isolation, enumeration, and molecular analysis of rare cells and cell-free DNA (cfDNA) from whole-blood samples. Achieving high target cell recovery and exceptional purity, the platform enables downstream molecular characterization of rare cells using next-generation sequencing (NGS), FISH and IHC.
The LiquidBiopsy Platform is part of a comprehensive, cost-effective workflow for the automated isolation, enumeration, and analysis of rare cells. High CTC capture rates are critical in patient monitoring applications because thereare usually less than 10 CTCs in a 7.5 mL whole blood sample (1 target cell per billion).
Sample multiplexing and a one-day blood drawto-sequence workflow accelerate turnaround time for higher- throughput laboratories.
The proprietary Cynvenio sheath flow chip uniquely supports patient monitoring applications. It achieves high purity while capturing CTCs using immunomagnetic positive selection. This flow chip enables low-input DNA sequencing without the need for whole-genome amplification. The chip can then be used to stain and scan the captured target cells.
Manufacture Specifications
Optimized LiquidBiopsy worflow
Up to a 48 hour turn-around
Variant detection: 0.1% to 1% sensitivity
CTC enrichment: 1 in a billion cells
Detects somatic & germline mutations
The flexible design of the LiquidBiopsy platform supports a variety of research areas, including:
Oncology
Endothelial Cells
Stem Cell Research
Fetal Cells / Noninvasive Prenatal Testing (NiPT)
Immunology
Peptide/Aptamer Libraries
Infectious Disease
Includes
Biohazard Waste Bin
Chip Tray
Reagant Rack Stabilizing Plate
Reagant Rack
Tip Rack
500 mL Wast Bottle with Biohazardous Label X2
Drainage Trough Tubing
Drainage Trough
0.5 mL PCR Tube Centrifuge Adapter
Gasket Insertion Tool
Elution Magnet
1X PBS CB - 034 X7
Additional Prep Fees May Apply.
